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In order to avoid misdiagnoses, medical imagers should be familiar with the normal patterns and 
distribution of FDG activity within the head and neck, as well as the pathophysiology and 
imaging-findings of common diagnostic pitfalls related to incidental FDG-avid lesions. The 
purpose of this article is to provide an image-rich review of the normal patterns of FDG uptake in 
the head and neck, help differentiate benign from malignant incidentally found FDG-avid foci, 
and detail important “don’t miss” hypometabolic head and neck lesions on PET/CT and 
PET/MRI. 
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Positron emission tomography/computed tomography (PET/CT) and, more 
recently, positron emission tomography-magnetic resonance imaging (PET/MRI) with 
fluorine-18-fluorodeoxyglucose (18F-FDG) are vital imaging modalities for the evaluation 
of numerous and histopathologically-varied neoplasms within the head and neck.1-3 An 
invaluable tool throughout the process of managing oncologic conditions, 18F-FDG 
PET/CT is regularly utilized in head and neck cancer imaging for the detection, initial 
diagnosis, and staging of tumors, evaluation of treatment response, monitoring for 
recurrence, and long-term surveillance.2,4,5 A newer technology, 18F-FDG PET/MRI is 
less established in the evaluation of head and neck cancer, but has shown promise 
given its superior tissue contrast resolution, lower ionizing radiation dose, and superior 
assessment of perineural tumor spread.  
Despite their tremendous utility, the accurate interpretation of 18F-FDG PET/CT 
and 18F-FDG PET/MRI requires comprehensive awareness and familiarity with many 
diagnostic challenges and pitfalls.6-10 Owing to the detailed and challenging anatomy of 
the region, as well confounding factors related to prior surgery and radiation, this 
requirement is only magnified with head and neck oncologic imaging.6,7,10 The purpose 
of this article is to provide a review of the normal patterns of 18F-FDG uptake in the head 
and neck, as well as imaging findings of common diagnostic pitfalls related to false-
negative exams and incidentally found 18F-FDG -avid foci in the head and neck on 
PET/CT and PET/MRI. 
Basics of FDG Physiology and Imaging: 
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Though a detailed exposition of the physiology, physics, and specific protocols 
for 18F-FDG PET/CT and 18F-FDG PET/MRI would far exceed the scope of this article, a 
brief preliminary discussion of the modality’s core elements is necessary for 
understanding its common interpretive pitfalls. The utility of PET in the evaluation of 
malignant tumors is premised on altered glucose metabolism.1,3,11 In order to meet their 
energy requirements, metabolically active tumor cells depend on glycolysis, which is 
promoted by the activation of the hexose monophosphate pathway and the upregulated 
expression of glucose transporter proteins and hexokinase within malignant cells.1,3,11 
As an analog of glucose, intravenously administered 18F-FDG is taken up by tumor cells 
via glucose transporter proteins and phosphorylated by hexokinase.1,11  However, unlike 
glucose-6-phophate, once phosphorylated, 18F-FDG does not undergo further 
metabolism in the glycolytic pathway.11 Rather, the phosphorylated 18F-FDG persistently 
accumulates1 and, due to the lack of requisite amount of glucose-6-phosphatase, 
remains trapped intracellularly within tumor cells.3,11 Consequently, 18F-FDG serves as a 
useful representation of the degree of glucose uptake throughout the body when the 
patient is subsequently imaged.3 
To allow for an appropriate degree of 18F-FDG uptake, imaging of the patient is 
typically performed approximately 60 – 90 minutes after 5 - 15 mCi (175 – 550 MBq) of 
18F-FDG have been administered intravenously.12 Whole-body CT was first employed in
conjunction with PET imaging primarily to supplement the modality by providing 
anatomic correlation and localization of molecular data and to enhance photon 
attenuation correction.2,6,11-13 However, with improved technologies and imaging 
techniques, PET imaging is now frequently combined not only with low-dose and/or 
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noncontrast CT but high-resolution, diagnostic-quality CT imaging or magnetic 
resonance imaging.5,14 The concurrent acquisition of high-resolution CT imaging or MRI 
often obviates the need for obtaining separate diagnostic-quality imaging,5 which is 
paramount in head and neck oncology for accurate staging and surgical planning.  
PET/CT and PET/MRI Imaging Pitfalls: 
While the increased utilization of hybrid 18F-FDG PET/CT has significantly 
improved the characterization of primary head and neck malignancies and the 
identification of locoregional and metastatic disease, accurate interpretation of the 
combined modality necessitates that imagers are familiar with its common imaging 
pitfalls. Most commonly, challenges and pitfalls in oncologic head and neck PET/CT or 
PET/MRI are related to physiologic uptake of 18F-FDG, incidental foci of increased 18F-
FDG uptake, and false-negative non-FDG avid lesions.6-10,15 Frequently encountered 
examples of physiologic 18F-FDG uptake include metabolic activity associated with 
normal lymphoid tissue, brown fat, thyroid and salivary gland tissue, and muscle 
activity.6-10,16 Incidental foci of increased 18F-FDG uptake can also be seen with vocal 
cord paralysis, incidental thyroid and salivary gland lesions, and infectious or 
inflammatory processes.6-10,16 Though less common, false-negative lesions may not be 
accurately characterized or missed due to location of the lesion and neoplastic 
characteristics, such as histopathologic type and tumor size and degree of necrosis.5-
10,12
Incidental FDG Uptake 
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Thyroid Gland Uptake 
On 18F-FDG PET imaging, the thyroid gland demonstrates variable 18F-FDG 
uptake and, due to incidental focal or diffusely increased metabolic activity, can present 
pitfalls for head and neck oncologic PET/CT or PET/MRI.7,10,15,17 Typically, physiologic 
18F-FDG uptake within the thyroid gland is either absent or minimal and homogeneous
in distribution.16-18 Additional patterns of 18F-FDG uptake within the thyroid gland include 
symmetric diffusely increased uptake and focal increased uptake, which can both be 
seen with physiologic, benign, and pathological conditions.6,7,10,19 Diffuse symmetric 
uptake of 18F-FDG within the thyroid gland usually represents either physiologic uptake 
or a benign etiology, such as multinodular goiter, Grave disease, or chronic autoimmune 
thyroiditis.7,10,17,19 (Figure 1) 
When focal 18F-FDG uptake within the region of the thyroid gland is identified on 
PET, it is important that the corresponding CT or MR images are carefully scrutinized, 
as the uptake can be mistakenly attributed to adjacent cervical nodal uptake.10,16,20 
Focal 18F-FDG uptake within the thyroid gland is nonspecific and can be seen with 
benign conditions, such as a thyroid adenoma, or in the setting of thyroid 
malignancy.6,7,10 The precise risk of malignancy in lesions with focal thyroid 18F-FDG 
uptake is equivocal with reported risk of malignancy ranging from 25-63%.10,18,21,22 As a 
result, it is recommended that foci of moderate to high 18F-FDG uptake undergo further 
diagnostic evaluation with thyroid ultrasound and/or fine-needle aspiration biopsy.6,7,10,18 
(Figure 2) 
Salivary Gland Uptake 
Downloaded for Anonymous User (n/a) at Indiana University Ruth Lilly Medical Library from ClinicalKey.com by Elsevier on July 22, 2019.













18F-FDG is normally taken up physiologically by the salivary glands and
subsequently excreted through the saliva.7,10 Accordingly, the parotid and 
submandibular glands usually demonstrate symmetric low to moderate 18F-FDG 
uptake,7,10,16 however the glands may occasionally demonstrate minimal or no uptake.7 
The normal physiologic uptake within the parotid and submandibular glands can both 
simulate and obscure salivary gland tumors.23 Additional patterns of 18F-FDG uptake 
within the salivary glands include diffusely increased uptake and asymmetric or focal 
increased uptake, which may present additional challenges to those interpreting 
PET/CT and PET/MRI of the head and neck.7,10  
There are a number of benign, non-neoplastic conditions that can result in 
increased 18F-FDG uptake within the salivary glands.7,10 For example, infectious 
etiologies, such as viral, bacterial, and tuberculous infections, radiation-induced 
sialadenitis, obstructive/calculous sialadenitis, and inflammatory conditions, such as 
sarcoidosis, can cause increased uptake within the salivary glands.6,7,10,24 (Figure 3) 
Asymmetric uptake can also be observed secondary to compensatory hypertrophy 
following contralateral gland resection.7,10  
In addition to non-neoplastic etiologies, salivary gland tumors can demonstrate 
increased 18F-FDG uptake, which is usually asymmetric and focal.6,7,10,23,25 (Figure 4) 
While high-grade tumors in the salivary gland tend to have higher 18F-FDG uptake than 
those of low or intermediate-grade,23 there are benign parotid gland tumors, such as 
papillary cystadenoma lymphomatosum (Warthin tumor) and pleomorphic adenoma 
(benign mixed tumor), which can also demonstrate increased uptake.6,7,10,23 
Additionally, it is important to note that some malignant salivary gland tumors may not 
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demonstrate significantly elevated 18F-FDG uptake, including low grade 
mucoepidermoid and adenoid cystic carcinomas.7,10,23 Thus, the lack of significant 
uptake within a salivary gland lesion does not exclude a malignant etiology.7 Due to the 
lack of definitive differentiation of benignity versus malignancy based on 18F-FDG 
uptake, focal asymmetric salivary gland uptake always requires careful evaluation of the 
associated CT or MRI component of the examination, as well as correlation with 
pertinent patient history.7 Additional imaging, such as ultrasound or high-resolution MRI 
may be complementary in better delineating lesion margins (circumscribed margins 
suggest a benign tumor or low grade malignancy; infiltrating margins suggest a high 
grade malignancy) and assessing lesion cellularity (low T2 or ADC signal intensity on 
MRI suggests a cellular tumor that is more likely to be malignant), but definitive 
diagnosis requires imaging-guided biopsy or surgical resection.10,25  
Brown Fat 
Within the human body, there are two morphologically and functionally distinct 
types of adipose tissue: white adipose tissue (WAT) and brown adipose tissue (BAT).26 
White adipose tissue has relatively low-level metabolic activity and primarily functions to 
provide energy storage and insulation.27-29 However, more than displaying these 
relatively inert characteristics, white adipose tissue, in so far as it secretes important 
hormones and cytokines and plays an important role in insulin resistance and 
inflammation, is now understood to also function as an endocrine organ.26,30 Brown 
adipose tissue, while also storing energy,26 mainly serves to produce heat, which can 
occur in the setting of cold temperatures (non-shivering thermogenesis) or following 
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food intake (diet-induced thermogenesis).26,28,29 In addition to its high vascularity, 
considerable sympathetic noradrenergic innervation, and adrenergic receptor 
expression, brown adipose tissue expresses a mitochondrial uncoupling protein.27-29 
This protein facilitates uncoupling of oxidative phosphorylation within mitochondria, 
which results in the direct production of heat instead of utilizing adenosine triphosphate 
(ATP).27-29 These physiologic processes have important implications, due to the 
resulting intense FDG uptake within brown adipose tissue on PET/CT and 
PET/MRI.10,27,31 
Typically, brown adipose tissue appears on 18F-FDG PET/CT and 18F-FDG 
PET/MRI as symmetric, fusiform-shaped, curvilinear foci of FDG uptake that correspond 
to areas of fat density (approximately -100 CT units) on CT images or fat signal intensity 
(T1 and T2 bright) on MR images.7,10,29 (Figure 5) BAT can be found in the axillae, 
intercostal spaces, and para-aortic and perinephric regions of the abdomen.29 However, 
most commonly and of critical importance for head and neck cancer imaging, brown 
adipose tissue is located within the deep cervical neck and supraclavicular 
regions.10,28,29 Though the precise demographics, including prevalence, and the factors 
contributing to the presence of brown adipose tissue on 18F-FDG PET/CT and 18F-FDG 
PET/MRI remain uncertain, BAT has been observed within the head and neck in 
approximately 2.5- 4.0% of imaged patients and has been overall more frequently 
observed in children,32 women, and during the winter months.31 Corresponding to the 
physiology of brown adipose tissue, proposed mechanisms to reduce 18F-FDG activity 
within BAT includes increasing ambient room temperature, application of warm 
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blankets, and the administration of medications prior to imaging, such as propranolol, 
diazepam, and fentanyl.7,29,31,32  
Muscle Uptake 
Due to the number and small size of muscles within the head and neck, 
physiologic muscle uptake of 18F-FDG represents an additional challenge for oncologic 
imaging of the head and neck.16 Physiologic muscle uptake of 18F-FDG can be 
observed with involuntary muscle activity (Figure 6), voluntary muscle activity (Figure 7), 
and in response to insulin administration or recent food ingestion.33 For example, focal 
uptake within the extraocular muscles can occur secondary to eye motion.10,16 With 
talking and phonation, 18F-FDG uptake may commonly be seen within the genioglossus, 
cricopharyngeus, and posterior cricoarytenoid muscles.10 Physiologic uptake associated 
with masseteric activity may also be seen with talking or chewing.33 Besides 18F-FDG 
uptake within particular muscle groups, diffuse skeletal uptake can also occur 
secondary to voluntary activity related to recent strenuous exercise.33  
In addition to uptake associated with these voluntary activities, 18F-FDG uptake is 
frequently observed within the sternocleidomastoid, longus colli, anterior scalene, 
longus capitis, and obliquus capitis inferior muscles due to anxiety associated muscle 
contraction.7,9,10,16,33,34 Similarly, scalene and sternocleidomastoid muscle uptake can be 
also be seen with coughing or labored breathing.33 In addition, if the patient is imaged 
following the administration of insulin or in the postprandial state, the patient may exhibit 
diffuse 18F-FDG skeletal muscle uptake.33,35 
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On 18F-FDG PET/CT and 18F-FDG PET/MRI, muscle uptake is reliably 
distinguished by mild to moderate symmetric and linear 18F-FDG uptake that can be 
followed on corresponding CT or MR images from the insertion of the muscle to its 
origin.6,10,35 The linearity may not always be evident on axial images and scrutinizing the 
coronal and sagittal reconstructed CT or acquired multiplanar MR images is helpful to 
demonstrate the typically linear configuration of uptake within the muscle or muscle 
group. In order to avoid the challenges associated with physiologic muscle uptake, 
certain preventative measures ought to be taken prior to imaging. The patient should be 
asked to fast for at least 4-6 hours35 and to refrain from intense exercise for at least 2435 
to 4833 hours prior imaging. Additionally, during the uptake component of the PET/CT of 
PET/MRI examination after 18F-FDG has been administered, the patient should be 
asked to remain as calm and relaxed as possible and to avoid any muscle activity, such 
as talking, chewing, or performing other physical activities that might promote FDG 
uptake.6,10,33,35 In order to help reduce anxiety-related muscle uptake, benzodiazepine 
administration prior to the examination can also be considered.10,35,36  
Vocal Cord Paralysis 
Occasionally, asymmetric 18F-FDG uptake within the vocal cords can present a 
diagnostic challenge on PET/CT or PET/MRI. Asymmetric 18F-FDG vocal cord uptake 
often occurs in the setting of unilateral vagus or recurrent laryngeal nerve injury, which 
may occur secondary to involvement of the nerve by a tumor or injury from prior surgery 
or trauma.7,10,37 In order to offset the paralysis of the affected vocal cord, the 
functioning, non-paralyzed contralateral vocal cord demonstrates compensatory 
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increased activity during phonation.7,10,37 (Figure 8) This heightened activity results in 
corresponding increased metabolism and glucose, particularly within the thyroarytenoid 
and posterior circoarytenoid muscles.10,38 It is imperative to scrutinize the associated 
anatomic CT or MR images through the level of the vocal cords, as focal uptake can 
simulate a lesion within the normal vocal cord.7,10  
On the PET component of PET/CT or PET/MRI, vocal cord paralysis, as a result 
of the compensatory increased activity and associated heightened metabolism and 
glucose uptake, results in focal avid 18F-FDG uptake within the non-paralyzed vocal 
cord.7,10,33,37 If asymmetric focal uptake is identified within a vocal cord, inspection of the 
contralateral vocal cord should be performed to assess for common imaging findings of 
paralysis or dysfunction. These findings typically include a paramedian location of the 
paralyzed vocal cord, dilated ipsilateral laryngeal ventricle (“Spinnaker sail” sign),39 
medialized and thickened ipsilateral aryepiglottic fold, dilated ipsilateral pyriform sinus, 
and, possibly, posterior cricoarytenoid and thyroarytenoid muscle atrophy.10,39-41   
In addition to the characteristic imaging features on CT of vocal cord paralysis, 
focal 18F-FDG uptake within the vocal cord should also be correlated with available 
pertinent patient clinical information.10 History and physical examination findings of 
hoarseness and a documented history of previous radiation or surgery to the neck or 
mediastinum may corroborate and explain observed imaging findings.10,41 Additionally, 
as vocal cord paralysis can be caused by disease occurring at any location from the 
brainstem to the distal aspect of the recurrent laryngeal nerves, it is imperative that the 
expected course of the involved vagus (jugular foramen and carotid space) and 
recurrent laryngeal nerves (tracheoesophageal groove bilaterally, aortopulmonary 
Downloaded for Anonymous User (n/a) at Indiana University Ruth Lilly Medical Library from ClinicalKey.com by Elsevier on July 22, 2019.













window on the left, and below subclavian artery on the right) are inspected on CT or MR 
images to evaluate for contributing pathology.39-41   
Lymphoid Tissue and Inflammatory Processes 
Focal increased 18F-FDG uptake within the head and neck on PET/CT or 
PET/MRI, which can potentially simulate a neoplastic process, is commonly 
encountered as result of physiological uptake within lymphoid tissue.6,7,9,16 The tissues 
of the head and neck are abound with lymphatic structures, including lymphatic 
channels, lymph nodes, and the nasopharyngeal (adenoid), palatine, and base of 
tongue (lingual) tonsillar tissue of the Waldeyer ring.6-8,10,16 Physiologic uptake within 
lymphoid tissue, which occurs secondary to the accumulation of 18F-FDG within 
lymphocytes and macrophages, can symmetric or asymmetric.6,7,10 Unfortunately, the 
pattern of uptake is not always helpful as symmetric uptake, though generally 
reassuring, can occasionally be seen with malignancy, such as in extra-nodal non-
Hogkin lymphoma and squamous cell carcinoma.6,10 Similarly, focal asymmetric uptake 
does not necessarily imply malignancy and can be seen with be seen with benign 
variant physiological uptake.6,7,10 In attempting to decipher benign from malignant 
etiologies on PET/CT or PET/MRI, it is imperative that the CT or MR images are 
carefully inspected for corresponding abnormalities, such as the presence of a mass 
lesion, morphological asymmetry, and loss of fat planes with infiltration of adjacent 
spaces and structures.10 Ultimately, equivocal findings require correlation with patient 
history and clinical evaluation, including endoscopy.10 
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In addition to physiological uptake within lymphoid tissue, there are numerous 
benign infectious, inflammatory, and granulomatous conditions that, as a result of 
increased glycolysis within macrophages, also commonly demonstrate focal 18F-FDG 
uptake and can mimic head and neck malignancy.6-8,10 Owing to chemotherapy-
associated immunosuppression, focal uptake at sites of infection or within reactive 
lymph nodes is frequently encountered with 18F-FDG PET/CT and 18F-FDG PET/MRI of 
head and neck malignancies.6,9 Similarly, focal 18F-FDG uptake is commonly seen with 
indwelling ports and catheters.6,10,42 Additional etiologies for inflammatory associated 
focal uptake within the head and neck include vasculitides, foreign body granulomas, 
and active atherosclerotic plaque.6,10 With active atherosclerotic plaque, 18F-FDG 
accumulates within plaque associated inflammatory cells, and the degree of uptake 
appears to correspond to the severity of vessel wall inflammation.6,10,43 (Figure 9) 
The interpretation of 18F-FDG PET/CT and 18F-FDG PET/MRI of head and neck 
malignancy is further complicated by the imaging pitfalls associated with postsurgical 
and recent radiation inflammatory changes.6,8-10 As a result of tissue injury, surgery 
generates an inflammatory response8,42 with the ensuing development of edema, 
granulation tissue, and scarring.10 The inflammatory process may have associated 
elevated 18F-FDG uptake, which, in addition to postsurgical anatomic changes on CT, 
can make evaluation on PET/CT or PET/MRI examinations performed after surgery 
challenging.6,8,10 As the uptake associated with postsurgical inflammatory changes 
steadily decreases over the few weeks after surgery, the first postoperative 18F-FDG 
PET/CT or 18F-FDG PET/MRI should optimally be delayed 4-6 weeks after surgery to 
avoid false-positive imaging findings.6,10 Similarly, while 18F-FDG PET/CT has shown to 
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be of significant utility in the evaluation of head and neck tumor recurrence,5,10 the focal 
18F-FDG uptake associated with postradiation inflammatory changes within the field of
radiation can simulate residual tumor or recurrence.4,6,10,12 Though the ideal timing 
remains uncertain and controversial,8 the first 18F-FDG PET/CT or 18F-FDG PET/MRI 
performed after radiation ought to be delayed at least 2-3 months to hopefully allow for 
resolution of the inflammatory changes and associated false-positive PET imaging 
findings.10   
Common False Negatives: 
In addition to incidental 18F-FDG uptake, imagers must be aware of the frequently 
encountered causes of false-negative head and neck 18F-FDG PET/CT or 18F-FDG 
PET/MRI examinations. Most commonly, false-negative studies within the head and 
neck are due to concerning lesions that may not demonstrate significant 18F-FDG 
uptake. There are a number of factors that may contribute to the observed lack of 
significant 18F-FDG uptake within tumors of the head and neck, including prior 
treatment, the tumor’s location, histopathological type, size, and degree of tumor 
necrosis.5,8,10,12 For example, false-negative results can be seen when tumors are 
located within areas that closely approximate tissues that have high physiologic 18F-
FDG uptake, such as lesions in or near the skull base that are close to the brain or 
tumors within the oral cavity that are near tonsillar tissue.6,10 Additionally, head and neck 
tumors or lymph nodes that are small in size (approximately 5-8 mm),12 can be missed 
or misinterpreted due to limitations of PET spatial resolution and partial volume 
effect.6,8,10,12  
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Besides a tumor’s size and location, false-negative results on head and neck 18F-
FDG PET/CT and 18F-FDG PET/MRI can be seen due to the particular histopathology 
type and degree of necrosis. Some types of malignancy that are commonly seen or can 
occur within the head and neck, such as well-differentiated thyroid cancer, adenoid 
cystic and mucoepidermoid salivary gland tumors, and spindle cell tumors, may 
demonstrate low 18F-FDG uptake, consequently producing false-negative findings.8,10 
Further, if the tumor or lymph node has significant necrosis, the lesion may demonstrate 
falsely-negative absent or low 18F-FDG uptake due to the lack of requisite metabolically 
active tissue.5,8,10 (Figure 10) Lastly, false-negative results on head and neck 18F-FDG 
PET/CT and 18F-FDG PET/MRI can also be observed on post-treatment imaging 
studies. While recent radiation and surgery are common causes of false-positive 
findings within the head and neck,6,8-10 radiation and chemotherapy can also contribute 
to false-negative results.6 If imaging is performed too early following the completion of 
radiation or chemotherapy, falsely-negative absent or low 18F-FDG uptake within the 
tumor may be observed due to altered kinetics of 18F-FDG uptake.6,12  
In addition to low uptake, false-negative head and neck 18F-FDG PET/CT and 
18F-FDG PET/MRI examinations can occur due to misleading symmetric 18F-FDG
accumulation within potentially concerning lesions. While most malignancies within the 
head and neck demonstrate asymmetric 18F-FDG uptake, some malignancies may 
manifest bilateral disease or may demonstrate metabolic symmetricity. For example, 
squamous cell carcinomas of the tongue base or nasopharynx may demonstrate 
bilateral 18F-FDG uptake.10 These instances of symmetric and bilateral 18F-FDG uptake 
emphasize the importance of carefully evaluating the CT and MR images for the 
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presence of associated suspicious findings, such as a mass lesion or the loss of normal 
fat planes.10 
Conclusions: 
18F-FDG PET/CT and 18F-FDG PET/MRI are essential tools for oncologic
imaging and of tremendous utility in the diagnosis and staging of head and neck cancer. 
However, the accurate interpretation of these modalities necessitates that head and 
neck imagers are cognizant of the many diagnostic challenges and pitfalls commonly 
found within the head and neck on 18F-FDG PET/CT and 18F-FDG PET/MRI. In order to 
avoid misdiagnosis, imagers should be familiar with the pathophysiology and normal 
patterns of 18F-FDG uptake within the head and neck, common false-negative (non-
FDG avid) lesions, and troubleshooting of incidental foci of 18F-FDG uptake. Moreover, 
head and neck imagers should be aware of the appropriate recommendations to 
provide referring clinicians when imaging pitfalls and challenges are encountered. 
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Figure 1. Incidental symmetric, diffusely increased thyroid FDG uptake. Fused axial 
FDG-PET/CT (a) in a patient with Hodgkin lymphoma demonstrates diffuse mildly 
increased thyroid gland FDG uptake (white arrows). The patient’s history and laboratory 
values were compatible with subclinical hypothyroidism. Fused axial FDG-PET/CT (b) in 
different patient with a history of Hodgkin lymphoma demonstrates significant diffuse 
thyroid gland uptake (white arrowheads). The patient’s history and laboratory values 
were also compatible with hypothyroidism. 
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Figure 2. Incidental focal thyroid FDG uptake. Fused axial FDG-PET/CT (a) 
demonstrates an enlarged thyroid gland with a small focus of mildly increased uptake 
within the left mid gland (white arrow) in a patient with a history of squamous cell 
carcinoma of the right maxilla presenting for initial staging. Ultrasound guided biopsy of 
the lesion was performed with pathology demonstrating benign thyroid nodule. Fused 
axial FDG-PET/CT (b) shows a focus of markedly increased uptake within the left lobe 
of the thyroid (white arrowhead) in a patient with a history of breast cancer status post 
lumpectomy and chemotherapy presenting for restaging. Ultrasound guided biopsy of 
the lesion was performed with pathology demonstrating follicular neoplasm. However, 
the lesion was subsequently resected with pathology demonstrating benign follicular 
nodule. 
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Figure 3. Asymmetric submandibular gland FDG uptake. Fused axial FDG-PET/CT (a) 
demonstrates asymmetric increased FDG uptake within the left submandibular gland 
(white arrow) relative to the right submandibular gland (white arrowhead). Axial NECT 
image in the same patient shows fatty atrophy of the right submandibular gland (black 
arrow) with associated large ductal calcifications (black arrowhead) from sialoliths that 
have chronically obstructed the submandibular duct. The left submandibular shows 
compensatory enlargement, but is otherwise normal in appearance. 
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Figure 4. Focal salivary gland FDG uptake. Fused axial FDG-PET/CT (a) shows a small 
focus of increased FDG uptake within the left superficial parotid gland (white 
arrowhead). Axial CECT (b) in the same patient shows a subtle idodense/isoenhancing 
nodule (black arrow) in the superficial parotid. Ultrasound-guided biopsy demonstrated 
poorly differentiated carcinoma. (c) Fused axial FDG-PET/CT (c) in a different patient 
with breast cancer presenting for initial staging demonstrates a small FDG avid mass 
within the right superficial parotid gland (white arrowhead). Axial CECT of the same 
patient (d) shows a corresponding enhancing mass within the right parotid gland (black 
arrowhead) corresponding to the focus of increased FDG uptake. Ultrasound-guided 
biopsy of the lesion demonstrated pleomorphic adenoma. 
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Figure 5. FDG uptake in brown adipose tissue. Fused axial FDG-PET/CT (a) shows 
bilateral focal FDG uptake within the supraclavicular regions (white arrows). 
Corresponding axial CECT image shows fat density (white arrowheads) corresponding 
to areas of uptake on FDG/PET, diagnostic of brown fat.  
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Figure 6. Involuntary muscular activity with FDG uptake. Fused axial PET/CT (a) shows 
symmetric increased FDG uptake along the posterior wall of the nasopharynx (white 
arrows). Axial NECT (b) shows corresponding normal appearance of the longus colli 
(black arrows), which is confirmed on (c) axial T1-weighted MRI (white arrowheads).  
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Figure 7. Voluntary muscular activity with FDG uptake. Fused axial PET/CT (a) shows 
bilateral FDG avidity (white arrows) posterior to the cricoid. Axial NECT (b) shows 
normal appearance of the postcricoid region bilaterally (black arrows), confirming that 
the FDG uptake was related to phonation activity involving the posterior cricoarytenoid 
muscles.  
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Figure 8. Asymmetric FDG uptake due to left-sided vocal cord paralysis. Fused axial 
FDG-PET/CT (a) shows the normally functioning right vocal cord (white arrow) with 
dramatically increased FDG uptake compared to the paralyzed left vocal cord. Note 
additional dilatation of the left laryngeal ventricle (black arrow) resulting in a “spinnaker 
sail” sign, as well as asymmetrically increased FDG uptake in the functional right 
posterior cricoarytenoid muscle (white arrowhead). Fused axial FDG-PET/CT at the 
level of the clavicles (b) shows a causative FDG avid metastatic lymph node (black 
arrowhead) that involved either the vagus or recurrent laryngeal nerve. 
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Figure 9. FDG uptake due to atherosclerosis. Fused axial FDG-PET/CT (a) in a patient 
with esophageal adenocarcinoma shows an isolated focus of hypermetabolic activity 
within the left suprahyoid neck (white arrow). A metastatic level II lymph node would be 
an unusual location for an isolated metastasis from esophageal carcinoma. 
Corresponding axial CECT (b) demonstrates that the area of uptake corresponds to the 
left internal carotid artery (black arrow) not a cervical chain lymph node. Note a “rim” 
sign of adventitial calcification, as well as eccentric soft tissue component in this patient 
with active inflammation from atherosclerotic disease with high-risk plaque ulceration 
and likely intraplaque hemorrhage. 
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Figure 10.  False negative FDG/PET due to necrotic lymph nodes. Fused axial FDG-
PET/CT (a) in a patient with left base of tongue squamous cell carcinoma (white arrow) 
shows two non-FDG avid masses in the left suprahyoid neck (black arrows). 
Corresponding axial CECT (b) shows these necrotic level II lymph nodes (white 
arrowheads) to be low density (fluid attenuation). Because of necrosis, these nodes do 
not have sufficient metabolic activity to register FDG uptake and are an important pitfall 
in head and neck oncologic imaging. 
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Figure 11.  Misleading near-symmetric FDG uptake. Fused coronal FDG-PET/MRI (T1-
weighted pre-contrast image) (a) in a patient with biopsy-proven neurolymphomatosis 
shows bilateral FDG uptake in the brachial plexus (white arrows). Fused axial FDG-
PET/MRI (T1-weighted post-contrast fat-saturated image) (b) shows the bilateral FDG 
uptake within the brachial plexus (black arrows) to be mildly greater on the right. 
Coronal T1 Dixon post-contrast fast-saturated MRI (c) shows marked enhancement 
(white arrowheads) of the enlarged (right greater than left) brachial plexus nerve roots. 
Axial DWI trace (d) shows markedly hyperintense brachial plexus (black arrowheads) 
bilaterally due to a combination of high cellularity lymphomatous infiltrate and intrinsic 
fractional anisotropy of the brachial plexus resulting in reduced diffusivity. This case 
shows the risk in assuming that “symmetry is your friend”; rather, symmetry may be 
your “frenemy”! 
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